Key result
CO2-assisted epicardial ablation successfully treats VT without disrupting adjacent substernal EV-ICD lead integrity.
Why the study?
As EV-ICD use increases, more patients requiring epicardial access for VT ablation will have a substernal lead in situ along the epicardial-access corridor, where subxiphoid puncture risks injuring it.
Case Report (n=1)
No
Percutaneous carbon-dioxide-assisted coronary-vein-exit epicardial access enables safe and effective epicardial VT ablation alongside a substernal EV-ICD lead without causing mechanical lead damage or requiring surgical access.
Answers are grounded in this paper and cite their sources.
May allow safe epicardial VT ablation near substernal leads; leaves open generalizability beyond single cases.
Structured abstract Background The extravascular implantable cardioverter-defibrillator (EV-ICD) places a single defibrillation lead in the substernal space, retaining antitachycardia pacing and defibrillation without intravascular hardware. As EV-ICD use increases, a larger proportion of patients requiring epicardial access for ventricular tachycardia (VT) ablation will have an EV-ICD in situ; the substernal lead lies along the epicardial-access corridor, where subxiphoid puncture risks injuring it. Case summary A 56-year-old man with prior inferior myocardial infarction (chronically occluded circumflex artery) and left-ventricular ejection fraction 39% presented with haemodynamically unstable monomorphic VT and received an EV-ICD for secondary prevention. Combined endocardial–epicardial ablation was performed. With device detection off, epicardial access was obtained percutaneously by carbon-dioxide insufflation through a coronary-vein branch and subxiphoid puncture into the gas-filled pericardial space, away from the substernal lead. High-density mapping showed inferolateral and basal-septal low-voltage areas; endocardial and epicardial radiofrequency applications abolished late potentials and rendered VT non-inducible. The lead was undamaged: high-voltage impedance was 100 Ω before and 95 Ω after ablation, with unchanged sensing, pacing impedance and no effusion. No sustained VT recurred over three months. Discussion Epicardial VT ablation can be performed safely alongside a substernal EV-ICD lead. Percutaneous carbon-dioxide-assisted coronary-vein-exit access opens a controlled pericardial plane away from the lead, mitigating the principal hazard of mechanical lead injury without the surgical access or lead manipulation described previously, and offers a transferable workflow with documented lead integrity.
No takes yet. Share an insight, caveat, or question.
Zaborska-Dworak et al. (2026) conducted a case report in Monomorphic ventricular tachycardia with a substernal extravascular implantable cardioverter-defibrillator (EV-ICD) in situ (n=1). Combined endocardial-epicardial VT ablation via percutaneous carbon-dioxide insufflation through a coronary-vein branch was evaluated on VT non-inducibility, sustained VT recurrence, and EV-ICD lead integrity. CO2-assisted epicardial VT ablation beside a substernal EV-ICD lead abolished VT with 0 recurrences at 3 months and preserved lead integrity (impedance 100 Ω pre vs 95 Ω post).
Synapse has enriched 10 related papers. Consider them for comparative context: